<DOC>
	<DOCNO>NCT00900380</DOCNO>
	<brief_summary>RATIONALE : Studying sample tissue patient cancer laboratory may help doctor learn cancer development drug resistance patient . PURPOSE : This laboratory study examine tissue sample patient acute myeloid leukemia learn drug resistance patient .</brief_summary>
	<brief_title>Studying Tissue Samples Learn More About Drug Resistance Patients With Acute Myeloid Leukemia</brief_title>
	<detailed_description>OBJECTIVES : - Ascertain whether assessment P-glycoprotein ( P-gp ) status use accumulation assay find great 10 % positive specimen among 30 specimen ( collected patient acute myeloid leukemia enrol clinical trial ECOG-E3999 ) find negative use efflux assay . OUTLINE : This multicenter study . Cryopreserved bone marrow specimen examine P-glycoprotein ( P-gp ) accumulation assay efflux assay use DiOC_2 dye . Flow cytometry use measure activity assay . PROJECTED ACCRUAL : A total 40 specimen accrue study .</detailed_description>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Cryopreserved bone marrow specimen collect patient acute myeloid leukemia enrol clinical trial ECOGE3999 meeting follow criterion : Appreciable level either CD34+ OR CD117+ blast Appreciable stain antiPgp antibody 30 specimen must exhibit low moderate dye load Rh123 efflux assay 10 specimen must exhibit positive Rh123 efflux activity PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>adult acute monocytic leukemia ( M5b )</keyword>
	<keyword>adult acute megakaryoblastic leukemia ( M7 )</keyword>
	<keyword>adult acute myeloblastic leukemia maturation ( M2 )</keyword>
	<keyword>adult acute myeloblastic leukemia without maturation ( M1 )</keyword>
	<keyword>adult acute myelomonocytic leukemia ( M4 )</keyword>
	<keyword>adult acute monoblastic leukemia ( M5a )</keyword>
	<keyword>secondary acute myeloid leukemia</keyword>
	<keyword>untreated adult acute myeloid leukemia</keyword>
	<keyword>adult acute minimally differentiate myeloid leukemia ( M0 )</keyword>
	<keyword>adult acute myeloid leukemia 11q23 ( MLL ) abnormality</keyword>
	<keyword>adult acute myeloid leukemia inv ( 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 16 ; 16 ) ( p13 ; q22 )</keyword>
	<keyword>adult acute myeloid leukemia ( 8 ; 21 ) ( q22 ; q22 )</keyword>
	<keyword>adult erythroleukemia ( M6a )</keyword>
	<keyword>adult pure erythroid leukemia ( M6b )</keyword>
</DOC>